Since the advent of scientific management in the late 19th century, investors have remained unpersuaded if not dismissive of human capital measures when determining the cumulative financial value of publicly traded companies. This reluctance stems from a perceived arbitrariness and empirical uncertainty that has attached to the measurement of workforce contributions to organizational value.